trending Market Intelligence /marketintelligence/en/news-insights/trending/vra70bk7hnle4yo4fk1t_a2 content esgSubNav
In This List

Tetra Bio-Pharma completes acquisition of PhytoPain Pharma

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Tetra Bio-Pharma completes acquisition of PhytoPain Pharma

Tetra Bio-Pharma Inc. said it completed the acquisition of the remaining 20% of PhytoPain Pharma Inc. for C$12.4 million.

The Canadian medical cannabis company paid C$248,000 in cash, C$2.2 million in promissory notes and issued 2,485,218 of its shares for the interest.